BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 32434703)

  • 1. Effect of physical and psychocognitive function and perceived health status on 12-month adverse cardiac events among implantable cardioverter-defibrillator recipients.
    Kim J; Choi J; Shin MS; Park JK; An M; Kim SH; Choi N; Lee MO; Heo S
    Heart Lung; 2020; 49(5):530-536. PubMed ID: 32434703
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Perceived support from healthcare professionals, shock anxiety and post-traumatic stress in implantable cardioverter defibrillator recipients.
    Morken IM; Bru E; Norekvål TM; Larsen AI; Idsoe T; Karlsen B
    J Clin Nurs; 2014 Feb; 23(3-4):450-60. PubMed ID: 24102743
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of age on quality of life in implantable cardioverter defibrillator recipients.
    Hamilton GA; Carroll DL
    J Clin Nurs; 2004 Feb; 13(2):194-200. PubMed ID: 14723671
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Posttraumatic stress symptoms and predicted mortality in patients with implantable cardioverter-defibrillators: results from the prospective living with an implanted cardioverter-defibrillator study.
    Ladwig KH; Baumert J; Marten-Mittag B; Kolb C; Zrenner B; Schmitt C
    Arch Gen Psychiatry; 2008 Nov; 65(11):1324-30. PubMed ID: 18981344
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comorbidity burden is associated with poor psychological well-being and physical health status in patients with an implantable cardioverter-defibrillator.
    Hoogwegt MT; Kupper N; Jordaens L; Pedersen SS; Theuns DA
    Europace; 2013 Oct; 15(10):1468-74. PubMed ID: 23608028
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Perceptions of healthcare professionals' support, shock anxiety and device acceptance among implantable cardioverter defibrillator recipients.
    Morken IM; Norekvål TM; Bru E; Larsen AI; Karlsen B
    J Adv Nurs; 2014 Sep; 70(9):2061-2071. PubMed ID: 24506575
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Benefit of the Wearable Cardioverter-Defibrillator in Protecting Patients After Implantable-Cardioverter Defibrillator Explant: Results From the National Registry.
    Ellenbogen KA; Koneru JN; Sharma PS; Deshpande S; Wan C; Szymkiewicz SJ
    JACC Clin Electrophysiol; 2017 Mar; 3(3):243-250. PubMed ID: 29759518
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patient and Partner Sexual Concerns During the First Year After an Implantable Cardioverter Defibrillator: A Secondary Analysis of the P+P Randomized Clinical Trial.
    Streur MM; Rosman LA; Sears SF; Steinke EE; Thompson EA; Dougherty CM
    J Sex Med; 2020 May; 17(5):892-902. PubMed ID: 32198104
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of mood disturbance and arrhythmia events in patients after cardioverter defibrillator implantation.
    Dunbar SB; Kimble LP; Jenkins LS; Hawthorne M; Dudley W; Slemmons M; Langberg JJ
    Depress Anxiety; 1999; 9(4):163-8. PubMed ID: 10431681
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiac perforation from implantable cardioverter-defibrillator lead placement: insights from the national cardiovascular data registry.
    Hsu JC; Varosy PD; Bao H; Dewland TA; Curtis JP; Marcus GM
    Circ Cardiovasc Qual Outcomes; 2013 Sep; 6(5):582-90. PubMed ID: 24002030
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peri-procedural routines, implantation techniques, and procedure-related complications in patients undergoing implantation of subcutaneous or transvenous automatic cardioverter-defibrillators: results of the European Snapshot Survey on S-ICD Implantation (ESSS-SICDI).
    Lenarczyk R; Boveda S; Haugaa KH; Potpara TS; Syska P; Jedrzejczyk-Patej E; Chauvin M; Sadoul N; Dagres N
    Europace; 2018 Jul; 20(7):1218-1224. PubMed ID: 29762683
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Survival after shock therapy in implantable cardioverter-defibrillator and cardiac resynchronization therapy-defibrillator recipients according to rhythm shocked. The ALTITUDE survival by rhythm study.
    Powell BD; Saxon LA; Boehmer JP; Day JD; Gilliam FR; Heidenreich PA; Jones PW; Rousseau MJ; Hayes DL
    J Am Coll Cardiol; 2013 Oct; 62(18):1674-1679. PubMed ID: 23810882
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ICD: a qualitative study of patient experience the first year after implantation.
    Kamphuis HC; Verhoeven NW; Leeuw R; Derksen R; Hauer RN; Winnubst JA
    J Clin Nurs; 2004 Nov; 13(8):1008-16. PubMed ID: 15533107
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exercise-based cardiac rehabilitation for adult patients with an implantable cardioverter defibrillator.
    Nielsen KM; Zwisler AD; Taylor RS; Svendsen JH; Lindschou J; Anderson L; Jakobsen JC; Berg SK
    Cochrane Database Syst Rev; 2019 Feb; 2(2):CD011828. PubMed ID: 30746679
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of Inappropriate Shocks and Other Health Outcomes Between Single- and Dual-Chamber Implantable Cardioverter-Defibrillators for Primary Prevention of Sudden Cardiac Death: Results From the Cardiovascular Research Network Longitudinal Study of Implantable Cardioverter-Defibrillators.
    Peterson PN; Greenlee RT; Go AS; Magid DJ; Cassidy-Bushrow A; Garcia-Montilla R; Glenn KA; Gurwitz JH; Hammill SC; Hayes J; Kadish A; Reynolds K; Sharma P; Smith DH; Varosy PD; Vidaillet H; Zeng CX; Normand ST; Masoudi FA
    J Am Heart Assoc; 2017 Nov; 6(11):. PubMed ID: 29122811
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of patient and partner quality of life and health outcomes in the first year after an implantable cardioverter defibrillator (ICD).
    Dougherty CM; Fairbanks AM; Eaton LH; Morrison ML; Kim MS; Thompson EA
    J Behav Med; 2016 Feb; 39(1):94-106. PubMed ID: 26345262
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes in the Physical Function and Psychological Distress from Pre-Implant to 1, 6, and 12 Months Post-Implant in Patients Undergoing Implantable Cardioverter Defibrillator Therapy.
    Kim J; Park JK; Choi J; Kim SH; On YK; Shin MS; Choi N; Heo S
    J Clin Med; 2020 Jan; 9(2):. PubMed ID: 31979074
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sex differences in implantable cardioverter-defibrillator outcomes: findings from a prospective defibrillator database.
    MacFadden DR; Crystal E; Krahn AD; Mangat I; Healey JS; Dorian P; Birnie D; Simpson CS; Khaykin Y; Pinter A; Nanthakumar K; Calzavara AJ; Austin PC; Tu JV; Lee DS
    Ann Intern Med; 2012 Feb; 156(3):195-203. PubMed ID: 22312139
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Procedure timing as a predictor of inhospital adverse outcomes from implantable cardioverter-defibrillator implantation: insights from the National Cardiovascular Data Registry.
    Hsu JC; Varosy PD; Parzynski CS; Chaudhry SI; Dewland TA; Curtis JP; Marcus GM
    Am Heart J; 2015 Jan; 169(1):45-52.e3. PubMed ID: 25497247
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Physical function of patients with implantable cardioverter-defibrillators.
    Kim JS; Pressler SJ; Welch JL; Damush T; Sloan RS; Wu J; Groh WJ
    J Cardiovasc Nurs; 2009; 24(5):398-409. PubMed ID: 19707100
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.